U.S. flag

An official website of the United States government

GRCh38/hg38 8p23.3(chr8:1739267-1891412)x1 AND See cases

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Aug 12, 2011
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000054224.6

Allele description [Variation Report for GRCh38/hg38 8p23.3(chr8:1739267-1891412)x1]

GRCh38/hg38 8p23.3(chr8:1739267-1891412)x1

Genes:
  • LOC126860278:CDK7 strongly-dependent group 2 enhancer GRCh37_chr8:1748222-1749421 [Gene]
  • LOC126860279:CDK7 strongly-dependent group 2 enhancer GRCh37_chr8:1791725-1792924 [Gene]
  • CLN8-AS1:CLN8 antisense RNA 1 [Gene - HGNC]
  • CLN8:CLN8 transmembrane ER and ERGIC protein [Gene - OMIM - HGNC]
  • LOC126860277:P300/CBP strongly-dependent group 1 enhancer GRCh37_chr8:1703542-1704741 [Gene]
  • ARHGEF10:Rho guanine nucleotide exchange factor 10 [Gene - OMIM - HGNC]
  • LOC121740708:Sharpr-MPRA regulatory region 8503 [Gene]
  • MIR3674:microRNA 3674 [Gene - HGNC]
  • MIR596:microRNA 596 [Gene - HGNC]
Variant type:
copy number loss
Cytogenetic location:
8p23.3
Genomic location:
Preferred name:
GRCh38/hg38 8p23.3(chr8:1739267-1891412)x1
HGVS:
  • NC_000008.11:g.(?_1739267)_(1891412_?)del
  • NC_000008.10:g.(?_1687433)_(1839578_?)del
  • NC_000008.9:g.(?_1674840)_(1826985_?)del
Links:
dbVar: nssv578264; dbVar: nsv532892
Observations:
1

Condition(s)

Name:
See cases [See the Variation display for details]
Identifiers:

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000081588GeneDx
criteria provided, single submitter

(Kaminsky et al. (Genet Med. 2011))
Pathogenic
(Aug 12, 2011)
maternalclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedmaternalyes1not providednot providednot providednot providedclinical testing

Citations

PubMed

An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities.

Kaminsky EB, Kaul V, Paschall J, Church DM, Bunke B, Kunig D, Moreno-De-Luca D, Moreno-De-Luca A, Mulle JG, Warren ST, Richard G, Compton JG, Fuller AE, Gliem TJ, Huang S, Collinson MN, Beal SJ, Ackley T, Pickering DL, Golden DM, Aston E, Whitby H, et al.

Genet Med. 2011 Sep;13(9):777-84. doi: 10.1097/GIM.0b013e31822c79f9.

PubMed [citation]
PMID:
21844811
PMCID:
PMC3661946

Details of each submission

From GeneDx, SCV000081588.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1maternalyesnot providednot providedDiscovery1not providednot providednot provided

Last Updated: Mar 26, 2023